Alnylam initiates trial for ALN-AGT01 RVR in hypertension patients pretreated with zilebesiran
Alnylam Pharmaceuticals is conducting a study to evaluate ALN-AGT01 RVR in adult patients with mild to moderate hypertension who have been pretreated with zilebesiran.